#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Factor IX deficiency Small for dates baby Cervix carcinoma recurrent Becker's muscular dystrophy Chronic graft versus host disease in skin Thermal burn Cortical dysplasia Congenital myopathy Urethral valves Cutaneous lupus erythematosus Nephrotic syndrome Neuronal ceroid lipofuscinosis Prolymphocytic leukaemia Fusarium infection Vaginal cancer More trials…

Learn about Rare Diseases

Haemophilia A without inhibitors – Diagnostics Rhabdomyosarcoma recurrent – Diagnostics Pemphigoid – Basic Information Pemphigoid – Life with Disease Leiomyosarcoma – Trials in Disease Ocular melanoma – Life with Disease Usher’s syndrome – Life with Disease Biotinidase deficiency – Trials in Disease Wiskott-Aldrich syndrome – Treatment Medulloblastoma recurrent – Trials in Disease More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Eik1003 Degarelix Zanamivir Abrocitinib Io102 Hydrochloride Corline Heparin Conjugate Anhydrous Cholestyramine Blood And Related Products M1P Dipotassium Salt Wt1/Il15/Il15Ra Mrna Dc GSKVX000000034794 Tx200-Tr101 Ide397 Mrna-3210 Fondaparinux Sodium Patritumab Deruxtecan Dexamethasone Base Isosorbide Dinitrate Gen1053 Cilazapril More therapies…

Learn about Your Condition

Retroperitoneal cancer Mucopolysaccharidosis III Malignant melanoma Patent ductus arteriosus Body mass index increased Mucosal inflammation Myocardial infarction Ehlers-Danlos syndrome Cholangiosarcoma Viral myocarditis Endometrial cancer stage III Desmoplastic melanoma Endocrine disorder Cystic fibrosis Neck pain More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe

🇦🇹 Austria

🇭🇷 Croatia

🇨🇿 Czech Republic

🇩🇰 Denmark

🇪🇪 Estonia

🇫🇮 Finland

🇫🇷 France

🇩🇪 Germany

🇮🇸 Iceland

🇮🇹 Italy

🇱🇻 Latvia

🇱🇹 Lithuania

🇳🇱 Netherlands

🇳🇴 Norway

🇵🇱 Poland

🇵🇹 Portugal

🇷🇴 Romania

🇸🇰 Slovakia

🇸🇮 Slovenia

🇪🇸 Spain

🇸🇪 Sweden

Duchenne muscular dystrophy gene carrier

Study on the Safety and Efficacy of Delandistrogene Moxeparvovec and Imlifidase for Patients with Duchenne Muscular Dystrophy with Pre-existing Antibodies

Not recruiting

1 1 1 1
Investigated Drugs:
- Imlifidase
- Delandistrogene Moxeparvovec
Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

Not recruiting

2 1 1
Investigated Drugs:
- Vesleteplirsen

1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Duchenne muscular dystrophy gene carrier

Study on the Safety and Efficacy of Delandistrogene Moxeparvovec and Imlifidase for Patients with Duchenne Muscular Dystrophy with Pre-existing Antibodies

Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies